ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.
scientific article published on 21 January 2014
Author/s
author: Olivier Hermine, Marie-Olivia Chandesris, Erinn Soucie, Emmanuel Gyan, David Launay, Patrice Dubreuil, Olivier Lortholary, Ludovic Lhermitte, Danielle Canioni, Gandhi Damaj, Isabelle Durieu
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.